Newbury Pharmaceuticals AB (publ) (STO:NEWBRY)
Sweden
· Delayed Price · Currency is SEK 3.080
+0.020 (0.65%)
Apr 29, 2025, 5:08 PM CET
STO:NEWBRY Market Cap
STO:NEWBRY has a market cap or net worth of 74.72 million as of April 29, 2025. Its market cap has decreased by -14.44% in one year.
Market Cap
74.72M
Enterprise Value
61.86M
Revenue
41.48M
Ranking
n/a
PE Ratio
n/a
Stock Price
3.08
Market Cap Chart
Since February 4, 2022, STO:NEWBRY's market cap has decreased from 245.97M to 74.72M, a decrease of -69.62%. That is a compound annual growth rate of -30.83%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Apr 29, 2025 | 74.72M | -12.50% |
| Dec 30, 2024 | 85.39M | 42.48% |
| Dec 29, 2023 | 59.93M | -56.08% |
| Dec 30, 2022 | 136.45M | -44.52% |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Swedish Orphan Biovitrum AB | 95.89B |
| Sectra AB | 54.76B |
| Getinge AB | 50.28B |
| Camurus AB | 34.60B |
| Medicover AB | 32.05B |
| AddLife AB | 20.81B |
| Vitrolife AB | 20.04B |
| Bonesupport Holding AB | 19.69B |